Sierra Oncology Jumps 36% on $1.9B Acquisition by GlaxoSmithKline
(Sierra Oncology) Shares of Sierra Oncology rose more than 36% in premarket on Wednesday after agreeing to be acquired by Sierra Oncology for $1.9 billion. The deal will see Sierra…
GSK Projects Profit Falls this Year, Holds Split Plans
GlaxoSmithKline expects earnings to fall by a mid-to high-single-digit percentage this year due to Covid disruptions and investments in new drug pipelines, according to Reuters. The world’s biggest vaccine maker…